gip and glp 1 receptor agonist GLP-1 Agonists – Peripheral Brain Understand GLP-1/GIP Dual Agonist Tirzepatide
Description
Gan J, et al
Reaven et al
Ongoing trials are evaluating their potential benefits in populations with type 2 diabetes mellitus and either CKD or MASLD [101,102]
Methods Event numbers for acute pancreatitis and patient-years of exposure (PYOs) were obtained from representatives of the pharmaceutical companies, or by literature research
Haut MW, Petros TV, Frank RG, Lamberty G
